Clinical Trials · NCT02995330
Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer
- Phase
- Phase 1
- Recruitment status
- Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Enrollment
- 3
- Start date
- Feb 2017
- Locations
- 1 site, United States
- Primary endpoint
- Prostate-specific Antigen (PSA) Response